Pancreatic Cancer Research

ResearcherJiangnan UniversityNo recent work listed

Yuzheng Xue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1020-7059; OpenAlex author ID A5027181959. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 4

  1. MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9. Co-author DOI 10.18632/aging.203344↗
  2. NEAT1/miR-101-dependent Up-regulation of DNA-PKcs Enhances Malignant Behaviors of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.7150/jca.58824↗
  3. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance. Co-author DOI 10.1007/s13277-012-0624-8↗
  4. DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-013-0846-4↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuanlong Gu · 1 shared paper, 2021 · strength 0.16
  2. Chuanqing Bao · 1 shared paper, 2021 · strength 0.16
  3. Hao Hu · 1 shared paper, 2021 · strength 0.16
  4. Zhao‐Shen Li · 2 shared papers, 2013 · strength 0.07
  5. Jian-Ping Li · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.